Pilot Trial of KD018 with Neo-Adj Concurrent Chemo-RT in PTs with Rectal CA
What is the purpose of this trial?
To investigate the grade 3-4 toxicity associated with a course of neo-adjuvant chemo-radiation with concomitant Capecitabine and KD018 in patients with T3-T4 and N0-N2, M0 rectal cancer
- 18 Years and older
- Yale Cancer Center
- Last Updated:
- Study HIC#: